How Bad is Malapposition? OCT Findings and Events

Most post-angioplasty findings with optical coherence tomography (OCT) were not associated with clinical adverse events. Exceptions were small intra-stent area, and significant malapposition.

¿Qué tan mala es la mala aposición? Hallazgos del OCT y eventos

Suboptimal findings after angioplasty are very common (almost expected), although their clinical implications are uncertain. This registry—recently published in JACC—was developed in an attempt to answer these questions.

The analysis included a total of 1290 consecutive patients with 1348 lesions who underwent angioplasty and had an OCT performed immediately after stenting.

OCT findings were registered to try and find an association between stenting and device-oriented adverse events (cardiac death, vessel-related infraction, stent thrombosis, and lesion revascularization).

The median follow-up was almost 4 years, and no association was observed between adverse events and stent edge dissection, plaque prolapse, thrombus, and malapposition after stenting. 

That notwithstanding, patients with very significant malapposition (total malapposed volume ≥7 mm3) had more events, thus resulting in an independent predictor (hazard ratio: 6.12; p = 0.003).


Read also: IVUS vs OCT to Guide PCI: Which Should We Choose?


At the 3, 6 and 9-month follow-up, very significant malapposition immediately after the procedure correlated with late malapposition and uncovered struts.

Conclusion

Most OCT findings after stenting are not associated with clinical events. The only exceptions may be small intra-stent area, which mainly correlates with revascularization, and very significant malapposition, which is associated with major adverse events.

Original Title: Clinical Implications of Post-Stent Optical Coherence Tomographic Findings: Severe Malapposition and Cardiac Events.

Reference: Byung Gyu Kim et al. JACC Cardiovasc Imaging 2021. Online ahead of print. doi: 10.1016/j.jcmg.2021.03.008. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...